Gå direkte til innhold

Vaccination research 2008 part I - general call

A total of up to 70 mill. NOK (14 mill. USD) is available for the period 2009-2011 to support researcher projects, user-driven innovation projects, young scientist grants, and centers in vaccination research. Norwegian institutions can apply, and international collaboration is encouraged.

Forskerprosjekt Velg
Brukerstyrt innovasjonsprosjekt Velg
Institusjonsforankret strategisk prosjekt Velg
Annet personlig stipend Velg
03.09.2008 12:00 CEST



Antatt tilgjengelige midler:

The call "Vaccination research 2008" consists of two parts:
- part I - general call: a total of up to 70 mill. NOK* or 14 mill. USD is available from the Research Council of Norway
- part II - joint Norwegian-Indian call**: a total of up to 30 mill. NOK* or 6 mill. USD is available from the Research Council of Norway, and matched funding is available from Department of Biotechnology, India

*The Research Council of Norway will conduct a joint evaluation of proposals submitted under the two parts based upon similar criteria of quality and relevance. The resulting allocations to the two parts could therefore differ from what is indicated above. Proposals for center support (Research Institution-based Strategic Project) are evaluated separately.
**The call will be published shortly, and some changes might apply

Application deadline is September 3rd 2008, 12:00 hrs (noon), Norwegian time.

Project start date is January 1st 2009 at the earliest. Projects should normally run for 3 years, and be completed by December 31st 2011 at the latest.

Føringer og viktige forhold for alle søknadstyper i utlysningen:

The following guidelines apply to “Vaccination research 2008 part I – general call”. (Please see separate call text to be published shortly for “Vaccination research 2008 part II – joint Norwegian-Indian call”).


The proposal must be within the field of global vaccination research, which is here defined as research aiming at providing existing and improved vaccines for marginalized populations, especially children, in low- and middle-income countries. This includes epidemiological studies, the development and evaluation of new or improved vaccines, implementation of vaccination strategies, and studies to measure the costs and outcomes of such strategies. Further, the proposal must be within the overall aims of the GLOBVAC programme as stated above.

This call will encourage, but is not restricted to, proposals focusing on:

  • diseases and health problems that account for a large proportion of the global disease burden
  • diseases and health problems that are neglected
  • thematic areas where Norway is strongly involved in health programmes and research
  • thematic areas where Norway has the capacity and competence to be in the international forefront

The following types of studies are included in this call:

  • development of diagnostic tools, and identification of the need for vaccination programmes based on epidemiological studies
  • development of new candidate vaccines and identification of optimal formulations and immunization regimens for new and existing vaccines
  • development of methods to assess vaccine-induced protection (immune correlates), toxicity and side-effects
  • determination of the impact of vaccination, including protective efficacy and effectiveness for relevant outcome parameters and the development of national surveillance systems
  • increasing the availability and ensuring equitable coverage of existing vaccines
  • stimulation of technology transfer to low- and middle-income countries, including improved strategies for cost-effective production of vaccines and the development of trial sites



Projects should normally run for a period of 3 years, and must be completed by the end of 2011.

Eligible applicants are public and private Norwegian institutions. Allocation of funds must contribute to developing high quality projects with participation of Norwegian research groups and/or institutions.

International collaboration is encouraged, including partnerships with low- and middle-income countries. Funding from the programme can be spent overseas. International research groups or institutions can access funding from the programme as partners on proposals from Norwegian public or private institutions. Proposals must define tasks and funding for each of the international collaborators of the project.

Capacity building: It should be demonstrated that the project can lead to research capacity building in Norway and, when applicable, amongst collaborative partners in low- and middle-income countries.

Budget:  Projects should have budgets with 1-5 million NOK annually funded from this programme. Exempt from this rule is center support, where the requested project outline/letter of intent can indicate a higher budget when clearly justified. Projects are encouraged to secure additional funding from other sources (eg. EU-funding, own funding). Further, projects with own/additional funding and projects that can demonstrate sustainable commitments from own institution or other sources during and/or beyond the project period are encouraged. It is recommended that partners/staff in low- and middle-income countries are paid according to local salary levels.

The scope of the project should be realistic within the time frame and budget limitations of the project.

Participation of master and PhD students and post doctoral fellows should be integral components of a larger project proposal. Proposals consisting of an individual fellowship only will not be given priority. (See special guidelines for Young Scientist Grants).

Scientific results should be made available to all partners in the project. It is strongly encouraged to publish in peer-review journals that are accessible to scientists in low- and middle-income countries if possible.


  • Applications (application form, project description and appendices) must be submitted electronically using “e-søknad”
  • The application and project description (a maximum of 10 pages, font Times New Roman 12 point, footnotes and references included) must be well structured and clearly written in English
  • Activities should be clearly described according to a timeline, and could be organized into work packages when appropriate
  • Milestones should be identified that can be used to easily follow the progress of the project.
  • Budget information should be detailed and clearly presented, and should, when necessary, be specified in the project description or in a separate attachment
  • Proposals should include considerations on ethics, capacity building and sustainability
  • All international cooperation must be documented


  • Evaluation will be based on scientific merits, relevance for the programme goals and the guidelines of this call, hereunder elements such as strength of the institution, strategic use of the funding and the probability for success.
  • International experts will be used in evaluation of  the scientific quality

The GLOBVAC programme board will evaluate and ultimately decide, and at its discretion, which projects will receive funding and the amount of the allocations